Cargando…

Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)

BACKGROUND: There are no current instruments to facilitate population screening for rosacea. OBJECTIVE: To develop and evaluate a screening instrument for rosacea applicable for population surveys. METHODS: A rosacea-specific screening instrument (Rosascreen), consisting of a subject-completed quest...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jerry, Leyden, James, Cribier, Bernard, Audibert, Fabien, Kerrouche, Nabil, Berg, Mats
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916529/
https://www.ncbi.nlm.nih.gov/pubmed/26834119
http://dx.doi.org/10.1177/1203475416629118
_version_ 1782438844580233216
author Tan, Jerry
Leyden, James
Cribier, Bernard
Audibert, Fabien
Kerrouche, Nabil
Berg, Mats
author_facet Tan, Jerry
Leyden, James
Cribier, Bernard
Audibert, Fabien
Kerrouche, Nabil
Berg, Mats
author_sort Tan, Jerry
collection PubMed
description BACKGROUND: There are no current instruments to facilitate population screening for rosacea. OBJECTIVE: To develop and evaluate a screening instrument for rosacea applicable for population surveys. METHODS: A rosacea-specific screening instrument (Rosascreen), consisting of a subject-completed questionnaire and screening algorithm, was developed based on current diagnostic criteria for rosacea. Three iterations were pilot tested and refined for clarity and sensitivity in adult outpatients with and without rosacea. RESULTS: Three subject groups were consecutively evaluated with iterations of the questionnaire at each centre (overall N = 121). The final version had a sensitivity of 93% to 100% for key diagnostic criteria, and use of the algorithm had a sensitivity of 100% for detection of rosacea and specificity of 63% to 71%. Most subjects found the questionnaire easy to understand and complete. CONCLUSION: Rosascreen, a subject-completed questionnaire and diagnostic algorithm, is a highly sensitive screening instrument that may facilitate estimation of rosacea prevalence in general populations.
format Online
Article
Text
id pubmed-4916529
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-49165292016-07-05 Development and Evaluation of a Rosacea Screening Instrument (Rosascreen) Tan, Jerry Leyden, James Cribier, Bernard Audibert, Fabien Kerrouche, Nabil Berg, Mats J Cutan Med Surg Original Articles BACKGROUND: There are no current instruments to facilitate population screening for rosacea. OBJECTIVE: To develop and evaluate a screening instrument for rosacea applicable for population surveys. METHODS: A rosacea-specific screening instrument (Rosascreen), consisting of a subject-completed questionnaire and screening algorithm, was developed based on current diagnostic criteria for rosacea. Three iterations were pilot tested and refined for clarity and sensitivity in adult outpatients with and without rosacea. RESULTS: Three subject groups were consecutively evaluated with iterations of the questionnaire at each centre (overall N = 121). The final version had a sensitivity of 93% to 100% for key diagnostic criteria, and use of the algorithm had a sensitivity of 100% for detection of rosacea and specificity of 63% to 71%. Most subjects found the questionnaire easy to understand and complete. CONCLUSION: Rosascreen, a subject-completed questionnaire and diagnostic algorithm, is a highly sensitive screening instrument that may facilitate estimation of rosacea prevalence in general populations. SAGE Publications 2016-02-01 2016-07 /pmc/articles/PMC4916529/ /pubmed/26834119 http://dx.doi.org/10.1177/1203475416629118 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Tan, Jerry
Leyden, James
Cribier, Bernard
Audibert, Fabien
Kerrouche, Nabil
Berg, Mats
Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)
title Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)
title_full Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)
title_fullStr Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)
title_full_unstemmed Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)
title_short Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)
title_sort development and evaluation of a rosacea screening instrument (rosascreen)
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916529/
https://www.ncbi.nlm.nih.gov/pubmed/26834119
http://dx.doi.org/10.1177/1203475416629118
work_keys_str_mv AT tanjerry developmentandevaluationofarosaceascreeninginstrumentrosascreen
AT leydenjames developmentandevaluationofarosaceascreeninginstrumentrosascreen
AT cribierbernard developmentandevaluationofarosaceascreeninginstrumentrosascreen
AT audibertfabien developmentandevaluationofarosaceascreeninginstrumentrosascreen
AT kerrouchenabil developmentandevaluationofarosaceascreeninginstrumentrosascreen
AT bergmats developmentandevaluationofarosaceascreeninginstrumentrosascreen
AT developmentandevaluationofarosaceascreeninginstrumentrosascreen